Avita Medical, Inc. Common Stock

RCELNASDAQ • USD
15.16 USD
↘ 0.06 (0.37%)🟢LIVE (AS OF 09:31 AM EST)
🟢Market: OPEN

Avita Medical, Inc. Common Stock (RCEL) is currently trading at $15.16. There is a divergence between signals — technical indicators rate "Buy" but underlying fundamentals lean "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, exceptional Return on Equity (116.4%) and a bullish Golden Cross on the moving averages. Furthermore, RCEL is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Nov 16, 2026.

Open?$15.19
High?$15.69
Low?$15.16
Prev. Close?$15.22
Volume?4.6K
Avg. Volume?520.9K
VWAP?$15.25
Rel. Volume?0.01x
Bid / Ask
Bid?$13.08 × 100
Ask?$17.52 × 100
Spread?$4.44
Midpoint?$15.30
Valuation & Ratios
Market Cap?482.3M
Shares Out?31.4M
Float?30.0M
Float %?97.6%
P/E Ratio?N/A
P/B Ratio?-15.54
EPS?-$1.14
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.
Employees
226
Market Cap
491.1M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
2012-03-08
Address
28159 AVENUE STANFORD
VALENCIA, CA 91355
Phone: 661-568-1317
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
0
Momentum?
98
Short Sent.?
54
Piotroski F-Score?4/9Mixed
Altman Z-Score?-9.33Distress
Confidence?51%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?9.35%Elevated
Short Interest?2.8M
Days to Cover?6.1
Free Float30.0M
Avg Daily Volume458.7K
Settlement Date2026-10-30
Financial Health
Current Ratio?1.20Adequate
Quick Ratio?0.99Weak
Cash Ratio?0.46Low
Debt/Equity?-1.47Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
75/100
P/E?
N/A▾
P/B?
S&P
97
-15.54CHEAP▾
P/S?
Peers
100
S&P
24
5.70FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-19.8CHEAP▾
EV/Sales?
Peers
100
S&P
27
6.11HIGH▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
116.4%STRONG▾
ROA?
S&P
3
-77.2%WEAK▾
Cash Flow & Enterprise
FCF?$-20152000
Enterprise Value?$517.3M
Fundamentals ratios updated end of day